Patient-Reported Outcome Measures Used for Clinical Assessment in Adults Across the National Cancer Institute Community Oncology Research Program Practices
PURPOSE: Patient-reported outcome measures (PROMs) have been used to monitor patient response during cancer treatment and have resulted in improved clinical outcomes. This study examined the use of PROMs implemented for clinical assessment across the National Cancer Institute Community Oncology Research Program (NCORP) community practices. METHODS: This study used data from the 2017 and 2022 NCORP cancer care delivery landscape surveys. Descriptive statistics were used to analyze survey item data. Logistic regression models examined the relationship between geographic region and the organizational characteristics of practice settings that used and recorded PROMS in the electronic health record (EHR). RESULTS: Although most practices routinely assessed distress in 2017 (87.8%) and 2022 (91.1%), only 32.1% of practices used PROMs aimed at assessing health-related quality of life (HRQOL) or symptoms in 2017 and the rate decreased in 2022 (23.2%). A wide variety of questionnaires were used to measure distress and HRQOL/symptoms. No geographic or organizational factors were associated with use of PROMs for distress, whereas practices in the West and those with lower cancer patient volume were less likely to use PROMs to assess HRQOL or symptoms. Geographic location and participation in the Oncology Care Model (OCM) were associated with recording distress screening PROMs in the EHR, whereas participation in the OCM was the only factor associated with recording HRQOL or symptom assessment PROMs. CONCLUSION: Given that most adults with cancer are treated in their communities, it is critical to gain a better understanding of the factors associated with the low use of PROMs for HRQOL/symptom assessment in community-based practices. Alternative models for collecting PROMs may be needed to minimize future inequities in patient-centered cancer care delivery.
Authors
- Susan Kenyon Parsons (ORCID: https://orcid.org/0000-0003-0282-6490)
- Andrew Michael McDonald (ORCID: https://orcid.org/0000-0003-1582-956X)
- Benjamin Movsas (ORCID: https://orcid.org/0000-0003-2703-9776)
- Heather B. Neuman (ORCID: https://orcid.org/0000-0001-7462-8333)
- Matthew Francis Hudson (ORCID: https://orcid.org/0000-0001-6568-9118)
- Wade T. Kyono (ORCID: https://orcid.org/0009-0005-1330-100X)
- Sarah T. Hawley (ORCID: https://orcid.org/0000-0001-5756-645X)
- Melissa Loh (ORCID: https://orcid.org/0000-0003-1958-2648)
- Melyssa Foust (ORCID: https://orcid.org/0009-0008-1645-5081)
- Emily Van Meter Dressler (ORCID: https://orcid.org/0000-0002-6054-7839)
- Mary Elizabeth Cooley (ORCID: https://orcid.org/0000-0001-5353-9542)
- Chandylen L. Nightingale (ORCID: https://orcid.org/0000-0002-2275-9849)
- Susan Parsons
- Scott Ramsey (ORCID: https://orcid.org/0000-0001-5972-8280)
- Jessica Lyness
- Stephanie L. Pugh (ORCID: https://orcid.org/0000-0002-5977-8912)
- Ruth Carlos
- Charles Drescher
- Christa Braun-Inglis
Institutions
- Prisma Health (US)
- Tufts Medical Center (US)
- Henry Ford Health System (US)
- University of Michigan (US)
- Henry Ford Hospital (US)
- University of Alabama at Birmingham (US)
- Dana-Farber Cancer Institute (US)
- NRG Oncology (US)
- Wake Forest University Health Sciences (US)
- Wake Forest University (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1200/op-26-00137
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.00